BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Batta A, Hatwal J. Excess cardiovascular mortality in men with non-alcoholic fatty liver disease: A cause for concern! World J Cardiol 2024; 16(7): 380-384 [PMID: 39086893 DOI: 10.4330/wjc.v16.i7.380]
URL: https://www.wjgnet.com/1948-5182/full/v16/i7/380.htm
Number Citing Articles
1
Kenneth Maiese. Cardiovascular and nonalcoholic fatty liver disease: Sharing common ground through SIRT1 pathwaysWorld Journal of Cardiology 2024; 16(11): 632-643 doi: 10.4330/wjc.v16.i11.632
2
Anmol Singh, Aalam Sohal, Akash Batta. Recent developments in non-invasive methods for assessing metabolic dysfunction-associated fatty liver diseaseWorld Journal of Gastroenterology 2024; 30(39): 4324-4328 doi: 10.3748/wjg.v30.i39.4324
3
Anmol Singh, Aalam Sohal, Akash Batta. GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitisWorld Journal of Gastroenterology 2024; 30(48): 5205-5211 doi: 10.3748/wjg.v30.i48.5205
4
Wen-Rui Hao, Chun-Han Cheng, Tzu-Hurng Cheng. Addressing the alarming link between nonalcoholic fatty liver disease and cardiovascular mortality in menWorld Journal of Cardiology 2024; 16(9): 502-507 doi: 10.4330/wjc.v16.i9.502
5
Chenlu Yang, Shuohua Chen, Baoyu Feng, Ying Lu, Yanhong Wang, Wei Liao, Shouling Wu, Li Wang. Association between menopause, body composition, and nonalcoholic fatty liver disease: A prospective cohort in northern ChinaMaturitas 2025; 192: 108148 doi: 10.1016/j.maturitas.2024.108148